Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Quest Diagnostics, Inc (NYSE: DGX) closed at $166.46 down -0.92% from its previous closing price of $168.01. In other words, the price has decreased by -$0.92 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
For a deeper understanding of Quest Diagnostics, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 1.05 whereas as Long-Term Debt/Eq ratio is at 0.91.
On January 06, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $169 to $174.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 17, 2024, whereas the target price for the stock was revised from $145 to $172.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when PREVOZNIK MICHAEL E sold 4,643 shares for $170.00 per share. The transaction valued at 789,310 led to the insider holds 38,117 shares of the business.
PREVOZNIK MICHAEL E bought 4,643 shares of DGX for $789,310 on Mar 17 ’25. On Mar 05 ’25, another insider, Doherty Catherine T., who serves as the EVP, Regional Businesses of the company, sold 5,370 shares for $174.13 each. As a result, the insider received 935,078 and left with 68,068 shares of the company.
Valuation Measures:
As of this moment, Quest’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.63, and their Forward P/E ratio for the next fiscal year is 15.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.87 while its Price-to-Book (P/B) ratio in mrq is 2.73.
Stock Price History:
Over the past 52 weeks, DGX has reached a high of $178.87, while it has fallen to a 52-week low of $125.42. The 50-Day Moving Average of the stock is 1.10%, while the 200-Day Moving Average is calculated to be 7.92%.
Shares Statistics:
A total of 111.00M shares are outstanding, with a floating share count of 110.35M. Insiders hold about 0.56% of the company’s shares, while institutions hold 91.43% stake in the company.
